Encompass Health Corporation Business Acquisition, Pro Forma Net Income (Loss)
Encompass Health Corporation (EHC) reported Business Acquisition, Pro Forma Net Income (Loss) of $85.70 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2023-11-01
- Encompass Health Corporation business acquisition, pro forma net income (loss) for the quarter ending 2023-09-30 was $85.70M, a 85.10% increase year-over-year.
- Encompass Health Corporation business acquisition, pro forma net income (loss) for the quarter ending 2023-06-30 was $91.40M, a 86.91% increase year-over-year.
- Encompass Health Corporation business acquisition, pro forma net income (loss) for the quarter ending 2023-03-31 was $87.80M, a 0.00% change year-over-year.
- Encompass Health Corporation business acquisition, pro forma net income (loss) for the quarter ending 2022-12-31 was $89.40M, a 5.30% decline year-over-year.
- Encompass Health Corporation business acquisition, pro forma net income (loss) for fiscal 2022 was $273.70M, a 34.10% decline from fiscal 2021.
- Encompass Health Corporation business acquisition, pro forma net income (loss) for fiscal 2021 was $415.30M, a 45.82% increase from fiscal 2020.
- Encompass Health Corporation business acquisition, pro forma net income (loss) for fiscal 2020 was $284.80M, a 21.06% decline from fiscal 2019.
- Encompass Health Corporation business acquisition, pro forma net income (loss) for fiscal 2019 was $360.80M, a 20.27% increase from fiscal 2018.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 3 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 12 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | $85.70M 10-Q · filed 2023-11-01 | $177.10M derived: sum of 2 quarters · filed 2023-11-01 | $266.30M 10-Q · filed 2023-11-01 | $354.30M derived: sum of 4 quarters · filed 2023-11-01 | ||||
| 2023-06-30 | $91.40M 10-Q · filed 2023-08-04 | $179.30M 10-Q · filed 2023-08-04 | $268.60M derived: sum of 3 quarters · filed 2023-08-04 | $314.90M derived: sum of 4 quarters · filed 2023-11-01 | ||||
| 2023-03-31 | $87.80M 10-Q · filed 2023-05-03 | $177.20M derived: sum of 2 quarters · filed 2023-05-03 | $223.50M derived: sum of 3 quarters · filed 2023-11-01 | $272.40M derived: sum of 4 quarters · filed 2023-11-01 | ||||
| 2022-12-31 | $89.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $135.70M derived: sum of 2 quarters · filed 2023-11-01 | $184.60M derived: sum of 3 quarters · filed 2023-11-01 | $273.70M 10-K · filed 2023-02-27 | ||||
| 2022-09-30 | $46.30M 10-Q · filed 2023-11-01 | $45.40M 10-Q · filed 2022-11-02 | $95.20M derived: sum of 2 quarters · filed 2023-11-01 | $184.30M 10-Q · filed 2023-11-01 | $181.80M 10-Q · filed 2022-11-02 | $277.40M derived: sum of 4 quarters · filed 2023-11-01 | ||
| 2022-06-30 | $48.90M 10-Q · filed 2023-08-04 | $48.70M 10-Q · filed 2022-08-04 | $136.70M 10-Q · filed 2023-08-04 | $136.20M 10-Q · filed 2022-08-04 | $231.10M derived: sum of 3 quarters · filed 2023-08-04 | $331.20M derived: sum of 4 quarters · filed 2023-08-04 | ||
| 2022-03-31 | $87.80M 10-Q · filed 2023-05-03 | $87.50M 10-Q · filed 2022-05-03 | $182.20M derived: sum of 2 quarters · filed 2023-05-03 | $282.30M derived: sum of 3 quarters · filed 2023-05-03 | $395.60M derived: sum of 4 quarters · filed 2023-05-03 | |||
| 2021-12-31 | $94.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $194.50M derived: sum of 2 quarters · filed 2023-02-27 | $307.80M derived: sum of 3 quarters · filed 2023-02-27 | $415.30M 10-K · filed 2023-02-27 | ||||
| 2021-09-30 | $100.10M 10-Q · filed 2022-11-02 | $100.00M 10-Q · filed 2021-11-02 | $213.40M derived: sum of 2 quarters · filed 2022-11-02 | $320.90M 10-Q · filed 2022-11-02 | $322.10M 10-Q · filed 2021-11-02 | $405.30M derived: sum of 4 quarters · filed 2022-11-02 | ||
| 2021-06-30 | $113.30M 10-Q · filed 2022-08-04 | $113.80M 10-Q · filed 2021-08-03 | $220.80M 10-Q · filed 2022-08-04 | $221.90M 10-Q · filed 2021-08-03 | $305.20M derived: sum of 3 quarters · filed 2022-08-04 | $383.60M derived: sum of 4 quarters · filed 2022-08-04 | ||
| 2021-03-31 | $107.50M 10-Q · filed 2022-05-03 | $191.90M derived: sum of 2 quarters · filed 2022-05-03 | $270.30M derived: sum of 3 quarters · filed 2022-05-03 | $304.40M derived: sum of 4 quarters · filed 2022-05-03 | ||||
| 2020-12-31 | $84.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $162.80M derived: sum of 2 quarters · filed 2021-11-02 | $196.90M derived: sum of 3 quarters · filed 2021-11-02 | $284.80M 10-K · filed 2021-02-26 | ||||
| 2020-09-30 | $78.40M 10-Q · filed 2021-11-02 | $77.70M 10-Q · filed 2020-11-02 | $112.50M derived: sum of 2 quarters · filed 2021-11-02 | $200.40M 10-Q · filed 2021-11-02 | $198.80M 10-Q · filed 2020-11-02 | |||
| 2020-06-30 | $34.10M 10-Q · filed 2021-08-03 | $33.70M 10-Q · filed 2020-07-31 | $121.70M 10-Q · filed 2021-08-03 | $121.10M 10-Q · filed 2020-07-31 | ||||
| 2019-12-31 | $68.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $166.30M derived: sum of 2 quarters · filed 2021-02-26 | $258.00M derived: sum of 3 quarters · filed 2021-02-26 | $360.80M 10-K · filed 2021-02-26 | $364.30M 10-K · filed 2020-02-27 | |||
| 2019-09-30 | $98.10M 10-Q · filed 2020-11-02 | $97.60M 10-Q · filed 2019-10-31 | $189.80M derived: sum of 2 quarters · filed 2020-11-02 | $292.60M 10-Q · filed 2020-11-02 | $296.70M 10-Q · filed 2019-10-31 | $321.90M derived: sum of 4 quarters · filed 2021-02-26 | ||
| 2019-06-30 | $91.70M 10-Q · filed 2020-07-31 | $91.20M 10-Q · filed 2019-07-31 | $194.50M 10-Q · filed 2020-07-31 | $193.70M 10-Q · filed 2019-07-31 | $223.80M derived: sum of 3 quarters · filed 2021-02-26 | $315.20M derived: sum of 4 quarters · filed 2021-02-26 | ||
| 2019-03-31 | $102.50M 10-Q · filed 2019-05-01 | $132.10M derived: sum of 2 quarters · filed 2021-02-26 | $223.50M derived: sum of 3 quarters · filed 2021-02-26 | $315.90M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $29.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $121.00M derived: sum of 2 quarters · filed 2021-02-26 | $213.40M derived: sum of 3 quarters · filed 2021-02-26 | $300.00M 10-K · filed 2021-02-26 | $301.80M 10-K · filed 2020-02-27 | |||
| 2018-09-30 | $91.40M 10-Q · filed 2019-10-31 | $89.20M 10-Q · filed 2018-10-31 | $183.80M derived: sum of 2 quarters · filed 2019-10-31 | $270.40M 10-Q · filed 2019-10-31 | $270.70M 10-Q · filed 2018-10-31 | $349.20M derived: sum of 4 quarters · filed 2021-02-26 | ||
| 2018-06-30 | $92.40M 10-Q · filed 2019-07-31 | $93.70M 10-Q · filed 2018-08-02 | $176.40M 10-Q · filed 2019-07-31 | $179.80M 10-Q · filed 2018-08-02 | $257.80M derived: sum of 3 quarters · filed 2021-02-26 | $327.90M derived: sum of 4 quarters · filed 2021-02-26 | ||
| 2018-03-31 | $84.00M 10-Q · filed 2019-05-01 | $165.40M derived: sum of 2 quarters · filed 2021-02-26 | $235.50M derived: sum of 3 quarters · filed 2021-02-26 | $302.00M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2017-12-31 | $81.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $151.50M derived: sum of 2 quarters · filed 2021-02-26 | $218.00M derived: sum of 3 quarters · filed 2021-02-26 | $289.00M 10-K · filed 2021-02-26 | ||||
| 2017-09-30 | $70.10M 10-Q · filed 2018-10-31 | $65.90M 10-Q · filed 2017-10-31 | $136.60M derived: sum of 2 quarters · filed 2018-10-31 | $207.60M 10-Q · filed 2018-10-31 | $198.40M 10-Q · filed 2017-10-31 | |||
| 2017-06-30 | $66.50M 10-Q · filed 2018-08-02 | $63.00M 10-Q · filed 2017-08-02 | $135.70M 10-Q · filed 2018-08-02 | $130.60M 10-Q · filed 2017-08-02 | ||||
| 2017-03-31 | $66.80M 10-Q · filed 2017-04-28 | |||||||
| 2016-09-30 | $63.50M 10-Q · filed 2017-10-31 | $62.00M 10-Q · filed 2016-10-28 | $127.00M derived: sum of 2 quarters · filed 2017-10-31 | $188.10M 10-Q · filed 2017-10-31 | $184.00M 10-Q · filed 2016-10-28 | |||
| 2016-06-30 | $63.50M 10-Q · filed 2017-08-02 | $62.60M 10-Q · filed 2016-07-29 | $122.30M 10-Q · filed 2017-08-02 | $120.70M 10-Q · filed 2016-07-29 | ||||
| 2016-03-31 | $57.90M 10-Q · filed 2017-04-28 | $58.00M 10-Q · filed 2016-04-28 | ||||||
| 2015-09-30 | $51.40M 10-Q · filed 2016-10-28 | $50.70M 10-Q · filed 2015-10-29 | $94.40M derived: sum of 2 quarters · filed 2016-10-28 | $136.80M 10-Q · filed 2016-10-28 | $136.60M 10-Q · filed 2015-10-29 | $193.20M derived: sum of 4 quarters · filed 2016-10-28 | ||
| 2015-06-30 | $43.00M 10-Q · filed 2016-07-29 | $42.70M 10-Q · filed 2015-07-30 | $85.80M 10-Q · filed 2016-07-29 | $85.20M 10-Q · filed 2015-07-30 | $141.80M derived: sum of 3 quarters · filed 2016-07-29 | $193.00M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2015-03-31 | $42.60M 10-Q · filed 2016-04-28 | $98.80M derived: sum of 2 quarters · filed 2016-04-28 | $150.00M derived: sum of 3 quarters · filed 2016-04-28 | $233.60M derived: sum of 4 quarters · filed 2016-04-28 | ||||
| 2014-12-31 | $56.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $107.40M derived: sum of 2 quarters · filed 2016-02-25 | $191.00M derived: sum of 3 quarters · filed 2016-02-25 | $237.50M 10-K · filed 2016-02-25 | ||||
| 2014-09-30 | $51.20M 10-Q · filed 2015-10-29 | $50.10M 10-Q · filed 2014-10-28 | $134.80M derived: sum of 2 quarters · filed 2015-10-29 | $181.30M 10-Q · filed 2015-10-29 | $181.60M 10-Q · filed 2014-10-28 | $215.00M derived: sum of 4 quarters · filed 2016-02-25 | ||
| 2014-06-30 | $83.60M 10-Q · filed 2015-07-30 | $85.00M 10-Q · filed 2014-07-29 | $129.60M 10-Q · filed 2015-07-30 | $132.70M 10-Q · filed 2014-07-29 | $163.80M derived: sum of 3 quarters · filed 2016-02-25 | $223.10M derived: sum of 4 quarters · filed 2016-02-25 | ||
| 2014-03-31 | $46.90M 10-Q · filed 2015-05-01 | $80.20M derived: sum of 2 quarters · filed 2016-02-25 | $139.50M derived: sum of 3 quarters · filed 2016-02-25 | $305.80M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $33.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $92.60M derived: sum of 2 quarters · filed 2016-02-25 | $258.90M derived: sum of 3 quarters · filed 2016-02-25 | $311.30M 10-K · filed 2016-02-25 | $323.20M 10-K · filed 2014-02-20 | |||
| 2013-09-30 | $59.30M 10-Q · filed 2014-10-28 | $58.20M 10-Q · filed 2013-10-29 | $225.60M derived: sum of 2 quarters · filed 2014-10-28 | $278.00M 10-Q · filed 2014-10-28 | $274.30M 10-Q · filed 2013-10-29 | |||
| 2013-06-30 | $166.30M 10-Q · filed 2014-07-29 | $165.20M 10-Q · filed 2013-07-30 | $218.70M 10-Q · filed 2014-07-29 | $216.10M 10-Q · filed 2013-07-30 | ||||
| 2012-12-31 | $46.70M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $93.90M derived: sum of 2 quarters · filed 2014-02-20 | $140.40M derived: sum of 3 quarters · filed 2014-02-20 | $184.80M 10-K · filed 2014-02-20 | ||||
| 2012-09-30 | $47.20M 10-Q · filed 2013-10-29 | $93.70M derived: sum of 2 quarters · filed 2013-10-29 | $138.10M 10-Q · filed 2013-10-29 | |||||
| 2012-06-30 | $46.50M 10-Q · filed 2013-07-30 | $90.90M 10-Q · filed 2013-07-30 | ||||||
| 2010-12-31 | $902.70M 10-K · filed 2013-02-19 | |||||||
| 2009-12-31 | $100.20M 8-K · filed 2012-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |